Vancomycin is an antibiotic used to treat serious infections caused by Gram-positive bacteria [1]. It is a glycopeptide antibiotic that works by inhibiting bacterial cell wall synthesis [1]. Vancomycin is typically administered intravenously for systemic infections, but oral formulations are used to treat Clostridium difficile infections in the intestines [1].
What kind of infections does Vancomycin treat?
Vancomycin is effective against a range of serious Gram-positive bacterial infections [1]. This includes methicillin-resistant Staphylococcus aureus (MRSA) infections, which are often resistant to other antibiotics [2]. It is also used for conditions like endocarditis, meningitis, osteomyelitis, pneumonia, and sepsis caused by susceptible bacteria [1]. For intestinal infections, oral vancomycin targets Clostridium difficile colitis [1].
How does Vancomycin work?
Vancomycin functions by interfering with the formation of peptidoglycan, a crucial component of bacterial cell walls [1]. It binds to the D-alanyl-D-alanine terminus of the peptide side chains of peptidoglycan precursors, preventing cross-linking and weakening the cell wall [1]. This ultimately leads to bacterial cell lysis and death [1].
What are the common side effects of Vancomycin?
Common side effects associated with vancomycin treatment include infusion-related reactions such as "red man syndrome," which is characterized by flushing and itching, and can be minimized by slowing the infusion rate [1]. Other side effects may include nausea, dizziness, and changes in blood cell counts [1]. Nephrotoxicity (kidney damage) and ototoxicity (hearing damage) are more serious, though less common, potential side effects that require careful monitoring [1].
When did Vancomycin become available?
Vancomycin was discovered in 1953 from a soil sample in Borneo and was introduced into clinical practice in 1958 [3]. Its development was a significant step in combating infections caused by bacteria resistant to penicillin [3].
Are there different forms of Vancomycin?
Yes, vancomycin is available in different formulations to suit various treatment needs [1]. Intravenous (IV) vancomycin is used for systemic infections, allowing it to reach the bloodstream and fight bacteria throughout the body [1]. Oral vancomycin is poorly absorbed from the gastrointestinal tract, making it ideal for treating Clostridium difficile infections localized within the intestines without significant systemic exposure [1].
What is the patent status of Vancomycin?
As a long-established antibiotic, vancomycin is an older drug and its original patents have long expired [4]. This means the compound itself is no longer protected by patent, allowing for the production of generic versions [4]. DrugPatentWatch.com provides information on drug patents and exclusivity periods for various medications.